Invention Grant
- Patent Title: Humanized AXL antibodies
- Patent Title (中): 人源化AXL抗体
-
Application No.: US13320060Application Date: 2010-05-11
-
Publication No.: US08841424B2Publication Date: 2014-09-23
- Inventor: Peter Wirtz , Jens Ruhe , Takeshi Takizawa , Tomoko Takayama
- Applicant: Peter Wirtz , Jens Ruhe , Takeshi Takizawa , Tomoko Takayama
- Applicant Address: DE Martinsried
- Assignee: U3 Pharma GmbH
- Current Assignee: U3 Pharma GmbH
- Current Assignee Address: DE Martinsried
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Priority: EP09006355 20090511; EP09006474 20090513
- International Application: PCT/EP2010/056487 WO 20100511
- International Announcement: WO2010/130751 WO 20101118
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/00 ; A61K39/395
Abstract:
The present invention refers to monoclonal humanized antibodies, which bind to the extracellular domain of the AXL receptor tyrosine kinase and which at least partially inhibit AXL activity.
Public/Granted literature
- US20120117670A1 HUMANIZED AXL ANTIBODIES Public/Granted day:2012-05-10
Information query
